Navigation Links
KV Pharmaceutical Sets Record Date for Stockholder Action by Written Consent
Date:12/15/2009

ST. LOUIS, Dec. 15 /PRNewswire-FirstCall/ -- KV Pharmaceutical Company ( KVa/KVb) today announced that on December 10, 2009, the Company received a written notice (the "Notice") executed by the Marc S. Hermelin Revocable Trust DTD 7/23/99, a stockholder of the Company, requesting that the Board of Directors of the Company (the "Board") fix a record date for stockholder action by written consent relating to the proposed appointment of John Sampson to fill a vacant director seat resulting from Ronald J. Kanterman's departure (the "Director Appointment").

As disclosed in the Company's Current Report on Form 8-K filed today with the U.S. Securities and Exchange Commission (the "SEC"), Mr. Kanterman resigned as a member of the Board, effective December 11, 2009.

Pursuant to the Delaware General Corporation Law and the Company's Certificate of Incorporation, stockholders may fill such director vacancy by written consent without a meeting. The Board has not approved the Director Appointment and is not seeking stockholder action with respect to the Director Appointment.

The Company's By-Laws provide that the Board shall fix a record date for stockholder action by written consent upon request by any stockholder of record to do so. Pursuant to the Company's By-Laws and in response to the Notice, the Board set a record date as of the close of business on December 18, 2009 to determine the Company's stockholders eligible to consent in writing to the adoption of the Director Appointment.

About KV Pharmaceutical Company

KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets, and acquires technology-distinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology distinguished products through ETHEX Corporation, a subsidiary that competes with branded products, and Ther-Rx
'/>"/>

SOURCE KV Pharmaceutical Company
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital
2. Transcept Pharmaceuticals Receives Notice of Allowance for Second U.S. Patent Application Covering Intermezzo(R)
3. Vion Pharmaceuticals Receives Complete Response Letter for Onrigin(TM) From The U.S. Food And Drug Administration
4. GeoInvesting.com Offers Insight Into Two Growing Chinese Pharmaceutical Firms
5. New Report Grades Sustainability Reporting of Top Pharmaceutical Companies
6. Ohr Pharmaceutical Selects Allen & Caron for Investor Relations, Corporate Communications
7. Published Data Demonstrate Arena Pharmaceuticals Lorcaserin Has Low Abuse Potential
8. Onyx Pharmaceuticals to Webcast Analyst Briefing on Development Program
9. China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009
10. New National Pharmaceutical Council Report Provides Guidance on Evaluating Comparative Effectiveness Studies
11. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... -- Auxilium Pharmaceuticals, Inc. (Nasdaq: AUXL ) today ... Bank Health Care Conference to be held May 29-30 ... Adrian Adams , Chief Executive Officer and President, ... and its product pipeline at 12:00 p.m. ET on ... http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The presentation will also be ...
(Date:5/24/2013)... , May 24, 2013  Sinovac Biotech ... provider of biopharmaceutical products in China ... operating subsidiary company of Sinovac, obtained the Certificate ... Certificate) from the China State and Food Administration ... bulk production plants, and its Changping filing and ...
(Date:5/24/2013)... England and BOSTON , May ... drug discovery and development company, is pleased to announce that it ... Consultant to augment the Company,s business development capabilities in ... has more than 15 years of experience in business development, licensing ... Perlegen Sciences, Inc., Roche Pharma ( Japan ), Nippon ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 2Sinovac Beijing Obtains China GMP Certificate Under the New GMP Guidelines 3Heptares Augments Business Development Capabilities in Japan and Other Asian Territories 2
... Medical Technologies, Inc., announced today the availability of ... ™ as a native application for Apple,s iPad® ... integrates functionality accessed on handheld devices directly with ... and interoperability solution PrimeSUITE ® 2011. ...
... Sciences International, Inc. (Nasdaq: BDSI ) today ... Mark A. Sirgo, President and Chief Executive Officer, will ... BDSI,s product pipeline, particularly BEMA Buprenorphine for the treatment ... Phase 3 efficacy study is anticipated in late September, ...
Cached Medicine Technology:Greenway's Remote Clinic PrimeMOBILE Available on Apple's iPad 2Greenway's Remote Clinic PrimeMOBILE Available on Apple's iPad 3BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences 2BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences 3
(Date:5/25/2013)... (PRWEB) May 25, 2013 Actos ... underway in U.S. District Court, Western District of Louisiana, ... According to a Case Management Order issued on May ... filing of contested motions in the Actos bladder cancer ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
(Date:5/25/2013)... States (PRWEB) May 25, 2013 ... largest underground shelter company in the US and ... underground structures for over 35 years. M.E. and ... U.S. Handbook of NBC Weapon Fundamentals and Shelter ... United States’ bible on shelter engineering. McCarthy is ...
(Date:5/25/2013)... On May 20, 2013 the Sydney Morning ... discuss or plan for their eventual demise, but it is ... a Must-Do List to help people properly arrange for their ... personal fact sheet.” , While not a formal document, this ... data. It may include a summary of assets, debts, ...
(Date:5/25/2013)... NY (PRWEB) May 25, 2013 On ... to brain cancer research and advocacy, comments on a ... Physics, that shows incorporating cold atmospheric plasma into brain ... , According to a Science Daily ... Physics (MPE), biologists and physicians demonstrated the “synergistic effect ...
(Date:5/25/2013)... May 25, 2013 According to world-renowned ... beautiful and powerful women that ever lived. Cleopatra’s legendary ... some of the most powerful men in her time. ... remedies to keep her skin glowing and fresh, from ... bees- wax, maringa oil and cyprus grass. , Cleopatra ...
Breaking Medicine News(10 mins):Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawsuit News: Bernstein Liebhard LLP Notes New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3
... as firm-wide resourceHOUSTON, March 2 Confirming their commitment ... WHR Architects announced that Laurie Waggener, RRT, IIDA, AAHID ... Resource Studio. A recognized leader in the field ... of research as a means of enhancing the value ...
... $1 Billion per YearJACKSONVILLE, Fla., March 2 ... announced its support of the Medical Group Management ... is intended to advance the adoption of standardized ... by January 1, 2010. MGMA estimates that machine-readable ...
... Corp. (Nasdaq: KOOL ), a leading developer and ... announced today that products derived from its Intellectual Property have ... cord blood in more than one million procedures since the ... cells have been used to reconstitute the blood cell forming ...
... BMRN ) announced today the appointment of Dr. ... (CMO). Dr. Fuchs will replace,longtime BioMarin CMO, Dr. Emil Kakkis. ... welcome Dr. Henry Fuchs to BioMarin. He is,uniquely qualified to ... and CEO, he has demonstrated a strength of vision and,execution ...
... Launch to Include 24-oz and Convenient 4-oz Travel ... Bioscience (Nasdaq: PURE ) today announced ... of PURE,s silver dihydrogen citrate (SDC)-based disinfectant as ... Laboratories, OneShot Plus product line. OneShot Plus ...
... Profitability in Fourth Quarter of Fiscal 2008OLDSMAR, Fla., ... Board: CCEL) (the "Company"), one of the world,s ... and an industry leader of innovative stem cell ... for the fiscal year ended November 30, 2008 ...
Cached Medicine News:Health News:Laurie Waggener Joins WHR Architects 2Health News:Availity Announces Support of Project SwipeIT 2Health News:Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone 2Health News:Thermogenesis Technology Products Surpass Processing of More Than One Million Units of Cord Blood Stem Cells at 10-Year Milestone 3Health News:BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer 2Health News:BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer 3Health News:BioMarin Appoints Dr. Henry J. Fuchs as Senior Vice President and Chief Medical Officer 4Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 2Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 3Health News:Sterifide Laboratories to Launch 'Powered by SDC' OneShot Plus Disinfectant and Deodorizer 4Health News:Cryo-Cell International, Inc. Reports Results for Fiscal 2008 2Health News:Cryo-Cell International, Inc. Reports Results for Fiscal 2008 3Health News:Cryo-Cell International, Inc. Reports Results for Fiscal 2008 4Health News:Cryo-Cell International, Inc. Reports Results for Fiscal 2008 5Health News:Cryo-Cell International, Inc. Reports Results for Fiscal 2008 6
... are ideal for PCR and ... any work where aerosol contamination ... for pipetting DNA/RNA solutions, infectious ... For applications requiring absolute sterility, ...
... ART Aerosol Resistant Tips offer a ... ART Tips are designed for applications such ... studies. In addition, ART Tips are excellent ... and forensic studies. ART Tips prevent aerosol ...
Diamond Filter Tips play a critical role in preventing aerosol-borne contamination. Also available sterilized (no need to autoclave) and certified free of detectable RNase, DNase, DNA, RNA, and prote...
1000 L, Racked, Pre-sterilized, 100 tips/rack Recommended for 500 and 1000 L pipettes....
Medicine Products: